logo
Nissan halts production of three models for Canada at two US plants, Nikkei reports

Nissan halts production of three models for Canada at two US plants, Nikkei reports

Yahooa day ago
TOKYO (Reuters) -Nissan Motor is suspending production of three vehicle models for Canada at its Tennessee and Mississippi plants amid mutual auto tariffs between the U.S. and Canada, the Nikkei reported on Wednesday.
The production halt, which began in May, affects the Pathfinder and Murano SUVs made in Tennessee and the Frontier pickup trucks produced in Mississippi, the report said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

TD Bank names Andrew Jensen to manage financial crime risk in Canada
TD Bank names Andrew Jensen to manage financial crime risk in Canada

Yahoo

timean hour ago

  • Yahoo

TD Bank names Andrew Jensen to manage financial crime risk in Canada

By Nivedita Balu TORONTO (Reuters) -TD Bank has appointed Andrew Jensen as the head of financial crime risk management in Canada, replacing interim head Stephen Joyce, according to a memo sent to staff by global anti-money laundering chief Jacqueline Sanjuas on Wednesday. The change is one of many at the Canadian lender as it undergoes a U.S. government-ordered anti-money laundering remediation program following a historic $3 billion penalty by U.S. regulators for lapses in its risk systems. Jensen joined TD in 2024 as the global head of sanctions as a part of the bank's move to hire experts with regulatory experience. He will retain global oversight of sanctions and report to Sanjuas, the memo said. Jensen spent over seven years at the U.S. Department of Treasury and also held senior roles at Citi and Scotiabank on global sanctions teams. The change is effective July 14, the memo said. A TD Bank spokesperson confirmed the move and the content of the memo. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Canadian pharmaceutical industry alarmed after Trump floats 200 per cent tariff
Canadian pharmaceutical industry alarmed after Trump floats 200 per cent tariff

Yahoo

timean hour ago

  • Yahoo

Canadian pharmaceutical industry alarmed after Trump floats 200 per cent tariff

WASHINGTON — An pharmaceutical industry representative says Canada likely isn't the main target of U.S. President Donald Trump's threat to impose a 200 per cent tariff on pharmaceutical imports — but his plan could still put parts of the Canadian sector in peril. Canadian Generic Pharmaceutical Association president Jim Keon says there's a risk that Canada will get caught in the crossfire as Trump pushes to reduce Americans' reliance on drugs imported from places like China and India. On Tuesday, Trump floated the idea of massive pharmaceutical tariffs but said he would give drug makers up to a year and a half before introducing the duties. Keon says Canadian exports amount to less than five per cent of all generic medicines sold in the U.S. But without access to the American market, he says, it might not be practical for some companies in Canada to continue producing certain generic medicines for the domestic market. Keon says there is hope that the economic and security agreement being negotiated between Canada and the United States will ensure pharmaceuticals remain tariff-free. This report by The Canadian Press was first published July 9, 2025. Kelly Geraldine Malone, The Canadian Press

Methode: Fiscal Q4 Earnings Snapshot
Methode: Fiscal Q4 Earnings Snapshot

Yahoo

timean hour ago

  • Yahoo

Methode: Fiscal Q4 Earnings Snapshot

CHICAGO (AP) — CHICAGO (AP) — Methode Electronics Inc. (MEI) on Wednesday reported a loss of $28.3 million in its fiscal fourth quarter. The Chicago-based company said it had a loss of 80 cents per share. Losses, adjusted for one-time gains and costs, came to 77 cents per share. The maker of electrical components for the auto and computer industries posted revenue of $257.1 million in the period. For the year, the company reported a loss of $62.6 million, or $1.77 per share. Revenue was reported as $1.05 billion. Methode expects full-year revenue in the range of $900 million to $1 billion. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on MEI at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store